Skip to main content
. 2020 Jul 23;16(7):e1008949. doi: 10.1371/journal.pgen.1008949

Fig 6. Spt16-1 is not required for H3K9me3 and H3K27me3 deposition in the developing new macronuclei.

Fig 6

Z-projections of immunolabelling with (A) H3K9me3-specific antibodies (green) or (B) H3K27me3-specific antibodies and staining with Hoechst (red) in control or SPT16-1 RNAi at early stages of development. Dashed white circles indicate the two developing MACs. White arrowheads indicate the MICs. The other Hoechst-stained nuclei are fragments from the maternal somatic MAC. Scale bar is 10 μm.